Glazer Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.8 Billion distributed in 254 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Enstar Group LTD with a value of $243M, Spring Works Therapeutics, Inc. with a value of $193M, Blueprint Medicines Corp with a value of $171M, Dun & Bradstreet Holdings, Inc. with a value of $162M, and Skechers Usa Inc with a value of $151M.
Examining the 13F form we can see an increase of $635M in the current position value, from $2.16B to 2.8B.
Glazer Capital, LLC is based out at New York, NY
Below you can find more details about Glazer Capital, LLC portfolio as well as his latest detailed transactions.
